282 related articles for article (PubMed ID: 32253936)
1. Impact of cytoreductive surgery on outcomes of metastatic appendiceal carcinoma: a real-world, population-based study.
Abdel-Rahman O
J Comp Eff Res; 2020 Apr; 9(6):431-439. PubMed ID: 32253936
[No Abstract] [Full Text] [Related]
2. Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery.
Uemura M; Qiao W; Fournier K; Morris J; Mansfield P; Eng C; Royal RE; Wolff RA; Raghav K; Mann GN; Overman MJ
BMC Cancer; 2017 May; 17(1):331. PubMed ID: 28506255
[TBL] [Abstract][Full Text] [Related]
3. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.
Asare EA; Compton CC; Hanna NN; Kosinski LA; Washington MK; Kakar S; Weiser MR; Overman MJ
Cancer; 2016 Jan; 122(2):213-21. PubMed ID: 26506400
[TBL] [Abstract][Full Text] [Related]
4. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
Ihemelandu C; Mavros MN; Sugarbaker P
Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
[TBL] [Abstract][Full Text] [Related]
5. Impact of adjuvant chemotherapy on outcomes in appendiceal cancer.
Kolla BC; Petersen A; Chengappa M; Gummadi T; Ganesan C; Gaertner WB; Blaes A
Cancer Med; 2020 May; 9(10):3400-3406. PubMed ID: 32189461
[TBL] [Abstract][Full Text] [Related]
6. Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal Dissemination.
Huang Y; Alzahrani NA; Chua TC; Morris DL
Dis Colon Rectum; 2017 Apr; 60(4):360-367. PubMed ID: 28267002
[TBL] [Abstract][Full Text] [Related]
7. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
8. Prolonged Survival in Peritoneal Metastatic Appendiceal Carcinoma Patients Treated With Combined Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Acs M; Gerken M; Zustin J; Blaj S; Isgandarova S; Piso P
J Surg Res; 2023 Mar; 283():839-852. PubMed ID: 36915011
[TBL] [Abstract][Full Text] [Related]
9. A real-world, population-based study of the outcomes of patients with metastatic colorectal cancer to the peritoneum treated with or without cytoreductive surgery.
Abdel-Rahman O
Int J Colorectal Dis; 2020 Apr; 35(4):719-725. PubMed ID: 32060606
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and Prognostic Features in Patients with Peritoneal Metastasis from Mucinous Adenocarcinoma, Adenocarcinoma with Signet Ring Cells, and Adenocarcinoid of the Appendix Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy.
Ihemelandu C; Sugarbaker PH
Ann Surg Oncol; 2016 May; 23(5):1474-80. PubMed ID: 26597367
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological features and prognosis of primary appendiceal adenocarcinoma].
Liang JW; Wang Z; Zhou ZX; Zhang XM; Hu JJ; Zhao P
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):616-9. PubMed ID: 23158998
[TBL] [Abstract][Full Text] [Related]
12. Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.
Choe JH; Overman MJ; Fournier KF; Royal RE; Ohinata A; Rafeeq S; Beaty K; Phillips JK; Wolff RA; Mansfield PF; Eng C
Ann Surg Oncol; 2015 Aug; 22(8):2578-84. PubMed ID: 25582740
[TBL] [Abstract][Full Text] [Related]
13. Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies.
Tsagkalidis V; Choe JK; Beninato T; Eskander MF; Grandhi MS; In H; Kennedy TJ; Langan RC; Maggi JC; Pitt HA; Alexander HR; Ecker BL
Ann Surg Oncol; 2024 Jul; 31(7):4203-4212. PubMed ID: 38594579
[TBL] [Abstract][Full Text] [Related]
14. Impact of Mucinous Histology on the Prognosis of Stage I-III Adenocarcinomas of the Appendix: a Population-Based, Propensity Score-Matched Analysis.
Widmann B; Warschkow R; Schmied BM; Marti L; Steffen T
J Gastrointest Surg; 2016 Aug; 20(8):1493-502. PubMed ID: 27120448
[TBL] [Abstract][Full Text] [Related]
15. The Role of Adjuvant Chemotherapy Following Right Hemicolectomy for Non-metastatic Mucinous and Nonmucinous Appendiceal Adenocarcinoma.
AlMasri SS; Paniccia A; Hammad AY; Pai RK; Bahary N; Zureikat AH; Medich DS; Celebrezze JP; Choudry HA; Nassour I
J Gastrointest Surg; 2022 Jan; 26(1):171-180. PubMed ID: 34291365
[TBL] [Abstract][Full Text] [Related]
16. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
Bignell MB; Mehta AM; Alves S; Chandrakumaran K; Dayal SP; Mohamed F; Cecil TD; Moran BJ
Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336
[TBL] [Abstract][Full Text] [Related]
17. Systemic chemotherapy and survival in patients with metastatic low-grade appendiceal mucinous adenocarcinoma.
Lu P; Fields AC; Meyerhardt JA; Davids JS; Shabat G; Bleday R; Goldberg JE; Nash GM; Melnitchouk N
J Surg Oncol; 2019 Sep; 120(3):446-451. PubMed ID: 31236958
[TBL] [Abstract][Full Text] [Related]
18. Patient Selection for Cytoreductive Surgery.
Grotz TE; Fournier KF; Mansfield PF
Surg Oncol Clin N Am; 2018 Jul; 27(3):443-462. PubMed ID: 29935682
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms.
Polanco PM; Ding Y; Knox JM; Ramalingam L; Jones H; Hogg ME; Zureikat AH; Holtzman MP; Pingpank J; Ahrendt S; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2016 Feb; 23(2):382-90. PubMed ID: 26429720
[TBL] [Abstract][Full Text] [Related]
20. Post-operative chemotherapy improves the survival of patients with well differentiated widespread metastatic appendiceal non-mucinous adenocarcinomas.
Yu T; Fan H; Lv Q; Li J; Wei L; Wang M; Dong J; Cai X
Ann Palliat Med; 2021 May; 10(5):5156-5170. PubMed ID: 34044560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
